Intrapericardial IGF-I improves cardiac function in an ovine model of chronic heart failure

Heart Lung and Circulation

Volumn 14, Issue 2, 2005, Pages 98-103

  Matthews, Kenneth G ^a   Devlin, Gerard P ^b   Stuart, Selwyn P ^a   Jensen, Juliet A ^b   Doughty, Robert N ^c   Conaglen, John V ^b   Bass, James J ^d  

^a RUAKURA RESEARCH CENTRE   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cardiac; Heart; Myocardial infarction; Myocardium

Indexed keywords

SODIUM CHLORIDE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFORMANCE; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SHEEP; TREATMENT OUTCOME;

EID: 21244480081     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2005.02.002     Document Type: Article

References (32)

1. Li Z, Bing O, Robinson K, Lakatta E. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 1997;272:H2313-9.
2. Sharov V, Sabbah H, Shimoyama H, Goussev A, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996;148:141-9.
3. Bing O. Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol 1994;26:943-8.
4. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1994;28:2005-16.
5. Cheng W, Kajstura J, Nitahara J, Li B, Reiss K, Liu Y, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 1996;226:316-27.
6. Matthews KG, Devlin GP, Conaglen JV, Stuart SP, Aitken WM, Bass JJ. Changes in IGFs in cardiac tissue following myocardial infarction. J Endocrinol 1999;163:433-45.
7. Dean R, Edmondson S, Burrell L, Bach L. Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction. J Histochem Cytochem 1999; 47:649-59.
8. Reiss K, Kajstura J, Zhang X, Li P, Szoke E, Olivetti G, et al. Acute myocardial infarction leads to upregulation of the IGF-I autocrine system, DNA replication, and nuclear mitotic division in the remaining viable cardiac myocytes. Exp Cell Res 1994; 213:463-72.
9. Li Q, Li B, Wang X, Leri A, Jana K, Liu Y, et al. Overexpression of insulin-like growth factor I in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997; 100:1991-9.
10. Lee W-L, Chen J-W, Ting C-T, Ishiwata T, Lin S-J, Korc M, et al. Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. Endocrinology 1999;140:4831-40.
11. Cittadini A, Stromer H, Katz S, Clark R, Moses A, Morgan J, et al. Differential cardiac effects of growth hormone and insulin-like growth factor I in the rat. Circulation 1996;93:800-9.
12. Ambler GR, Johnston BM, Maxwell L, Gavin JB, Gluckman PD. Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I. Cardiovasc Res 1993; 27:1368-73.
13. Duerr R, Huang S, Miraliakbar H, Clark R, Chien K, Ross J. Insulin-like growth factor I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619-27.
14. Donath MY, Froesch ER, Zapf J. Insulin-like growth factor I and cardiac performance in heart failure. Growth Horm IGF Res 1998;8:167-70.
15. Jones J, Clemmons D. Insulin-like growth factors and their binding proteins: biological actions. Endoc Rev 1995; 16:3-34.
16. Matthews KG. The insulin-like growth factors in the ischaemic heart. Ph.D. thesis, Department of Medicine, University of Auckland; 2001. p. 1-248.
17. Devlin GP, Matthews KG, McCracken G, Stuart SP, Jensen JA, Conaglen JV, et al. An ovine model of chronic stable heart failure. J Cardiac Fail 2000;6:140-3.
18. Breier BH, Gallaher BW, Gluckman PD. Radioimmunoassay for insulin-like growth factor I: solutions to some potential problems and pitfalls. J Endocrinol 1991;128:347-57.
19. Hua KM, Ord R, Kirk S, Li QJ, Hodgkinson SC, Spencer GS, et al. Regulation of plasma and tissue levels of insulin-like growth factor I by nutrition and treatment with growth hormone in sheep. J Endocrinol 1993;136:217-24.
20. Hua KM, Hodgkinson SC, Bass JJ. Differential regulation of plasma levels of insulin-Like growth factors I and II by nutrition, age and growth hormone treatment in sheep. J Endocrinol 1995; 147:507-16.
21. D'Ercole AJ, Underwood L. Estimation of tissue concentrations of somatomedin C/insulin-like growth factor I. Methods Enzymol 1987;146:227-33.
22. Donath M, Jenni R, Brunner H-P, Anrig M, Kohli S, Glatz Y, et al. Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans. J Clin Endocrinol Metab 1996;81:4089-94.
23. Donath M, Sutsch G, Yan X-W, Piva B, Brunner H-P, Glatz Y, et al. Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinl Metab 1998; 83:3177-83.
24. Guler H-P, Eckardt K-U, Zapf J, Bauer C, Froesch ER. Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol 1989;121: 101-6.
25. Hodgkinson SC, Moore L, Napier JR, Davis SR, Bass JJ, Gluckman PD. Characterization of insulin-like growth factor binding proteins in ovine tissue fluids. J Endocrinol 1989; 120:429-38.
26. Bellomo R, Ronco C. The kidney in heart failure. Kidney Int 1998;53:58-61.
27. Donath M, Zierhut W, Gosteli-Peter M, Hauri C, Froesch ER. Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat. Eur J Endocrinol 1998;139:109-17.
28. Donath M, Gosteli-Peter M, Hauri C, Froesch ER, Jurgen Z. Insulin-like growth factor I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart. Eur J Endocrinol 1997;137:309-15.
29. Donath M, Zapf J, Eppenberger-Eberhardt M, Froesch ER, Eppenberger H. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci USA 1994;91:1686-90.
30. Matthews KG, Devlin GP, Stuart SP, Conaglen JV, Bass JJ. Cardiac IGF-I manipulation by growth hormone following myocardial infarction. Growth Horm IGF Res 2004;14:251-60.
31. Lehnart S, Schillinger W, Pieske B, Prestle J, Just H, Hasenfuss G. Sarcoplasmic reticulum proteins in heart failure. Ann NY Acad Sci 1998;853:220-30.
32. Arai M, Alpert N, MacLennan D, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. Circ Res 1993;72:463-9.